Original ResearchPublished 8 October 2026Availability and reimbursement of fixed-dose combination medicines for hypertension treatment in Central and Eastern EuropeRafał Nowak · Przemysław Holko · Iris Hoxha · Alexandra Savova · Pero Draganić · Jana Skoupa · Agnes Männik · Zoltán Kaló · Arturs Praskilevics · Kristina Garuoliene · Ljubica Shuturkova · Elena Chitan · Natasa Duborija-Kovacevic · Michał Owca · Ioana Bianchi-Manaila · Nikola Stefanovic · Tomas Tesar · Tamás Ágh · Paweł KawalecFrontiers in Pharmacologydoi 10.3389/fphar.2026.1889485
PerspectivePublished 7 October 2026Prediction without intervention: why fifteen years of no-show models have not closed the loop on patient adherenceDavid FlagelFrontiers in Digital Healthdoi 10.3389/fdgth.2026.1949255
PerspectivePublished 3 September 2026Making periodontal risk visible: the role of artificial intelligence in recall adherencePrajakta KarkareFrontiers in Dental Medicinedoi 10.3389/fdmed.2026.1927437
Original ResearchPublished 22 May 2026A two-tier protection strategy for oral delivery of GLP-1 peptides: lipid-based formulation combined with enteric capsulesCamille Dumont · Vanessa Gonzalez · Paula Klatt · Sandrine Picco · Delphine Nombret · Marine Agisson · Euengla Uku · Thibault Saurel · Vincent JanninFrontiers in Drug Deliverydoi 10.3389/fddev.2026.1770094
Musculoskeletal DisordersPublished 13 December 2023Screening practices, efficacy, safety and adherence to biologic therapies in a South African tertiary hospitalMohammed Awad Eltoum Ahmed · Christiaan Scott · Ayanda Gcelu · Jonel Steffen · Thuraya Isaacs · Bridget HodkinsonFrontiers in Musculoskeletal Disordersdoi 10.3389/fmscd.2023.1281548
